• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP - SUPERDIMENSION INC SUPERDIMENSION; SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP - SUPERDIMENSION INC SUPERDIMENSION; SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED Back to Search Results
Model Number AAS00161-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Hypoxia (1918); Pneumothorax (2012); Blood Loss (2597)
Event Date 07/11/2019
Event Type  Injury  
Manufacturer Narrative
Title: improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (enb) source radiation oncology, volume 14, 2019 (1-8) article number: 24 date of publication: 11-jul-2019.If information is provided in the future, a supplemental report will be issued.[(b)(4)].
 
Event Description
According to the literature source of study performed to patients who received robotic sabr for lung tumors from may 2015 until january 2017, all patients used superdimension.A total of 128 patients with 147 treated lung lesions were identified.Enb using the superdimension was used to guide fiducial marker placement with and without the superdimension fiducial wizard tool.Patients in whom the superdimension fiducial wizard tool are called the ¿fpgs group¿ and patients in whom superdimension was used without the fiducial wizard tool are called ¿non-fpgs group¿.Complications for fiducials placed in lesions that used the fpgs (n = 44) included pneumothorax (2.27%) and bleeding (2.27%), ctcae grade i and ii, respectively.For the lesions that did not utilize the fpgs (n = 103), complications included one incidence of grade ii pneumothorax (0.97%).The non-fpgs cohort did also have two incidences of hypoxia and one of hypotension.It will be noted that the two that developed a pneumothorax were undergoing concurrent biopsy and fiducial placement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERDIMENSION
Type of Device
SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED
Manufacturer (Section D)
COVIDIEN LP - SUPERDIMENSION INC
161 cheshire lane, suite 100
plymouth MN 55441
Manufacturer (Section G)
COVIDIEN LP - SUPERDIMENSION INC
161 cheshire lane, suite 100
plymouth MN 55441
Manufacturer Contact
amy beeman
161 cheshire lane, suite 100
minneapolis, MN 55441
7632104064
MDR Report Key8931886
MDR Text Key160128444
Report Number3004962788-2019-00061
Device Sequence Number1
Product Code JAK
UDI-Device Identifier10884521199989
UDI-Public10884521199989
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151376
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
Report Date 08/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAAS00161-20
Device Catalogue NumberAAS00161-20
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/02/2019
Initial Date FDA Received08/26/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-